Meta-Analysis of the Relationship Between Non–High-Density Lipoprotein Cholesterol Reduction and Coronary Heart Disease Risk
- 27 January 2009
- journal article
- research article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 53 (4), 316-322
- https://doi.org/10.1016/j.jacc.2008.10.024
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Lipoprotein Management in Patients With Cardiometabolic RiskJournal of the American College of Cardiology, 2008
- Efficacy and Safety of Atorvastatin in the Prevention of Cardiovascular End Points in Subjects With Type 2 DiabetesDiabetes Care, 2006
- Relative Efficacy of Atorvastatin 80 mg and Pravastatin 40 mg in Achieving the Dual Goals of Low-Density Lipoprotein Cholesterol <70 mg/dl and C-Reactive Protein <2 mg/lJournal of the American College of Cardiology, 2005
- Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2Circulation, 2004
- Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III GuidelinesCirculation, 2004
- MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trialThe Lancet, 2002
- Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsNew England Journal of Medicine, 1998
- Bayesian approaches to random‐effects meta‐analysis: A comparative studyStatistics in Medicine, 1995
- Marginal Likelihood from the Gibbs OutputJournal of the American Statistical Association, 1995
- Bayes FactorsJournal of the American Statistical Association, 1995